In Monday’s Wall Street session, Unitedhealth Group Inc (NYSE:UNH) shares traded at $425.33, down -6.34% from the previous session.
UNH stock price is now -16.76% away from the 50-day moving average and -22.55% away from the 200-day moving average. The market capitalization of the company currently stands at $389.05B.
On January 10, 2025, HSBC Securities Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock keeping its target price maintained at $595, while ‘Truist’ rates the stock as ‘Buy’
In other news, FLYNN TIMOTHY PATRICK, Director bought 1,000 shares of the company’s stock on Jan 17 ’25. The stock was bought for $511,575 at an average price of $511.57. Upon completion of the transaction, the Director now directly owns 4,500 shares in the company, valued at $1.91 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 11 ’24, EVP & Chief People Officer McSweeney Erin sold 701 shares of the business’s stock. A total of $438,987 was realized by selling the stock at an average price of $626.23. This leaves the insider owning 7,105 shares of the company worth $3.02 million. A total of 0.21% of the company’s stock is owned by insiders.
During the past 12 months, Unitedhealth Group Inc has had a low of $438.50 and a high of $630.73. According to the stock market information, the enterprise value for the company is $441790955520, which is based on a 17.78 price-to-earnings ratio, a 1.86 price-to-earnings-growth ratio, and a beta of 0.64. The fifty day moving average price for UNH is $510.9462 and a two-hundred day moving average price translates $549.1945 for the stock.
The latest earnings results from Unitedhealth Group Inc (NYSE: UNH) was released for 2025-03-31. The net profit margin was 5.39% and return on equity was 15.88% for UNH. The company reported revenue of $100.81 billion for the quarter, compared to $94.43 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.76 percent.
